Mandy B Belfort1, Karl C K Kuban2, T Michael O'Shea3, Elizabeth N Allred4, Richard A Ehrenkranz5, Stephen C Engelke6, Alan Leviton4. 1. Department of Pediatric Newborn Medicine, Brigham and Women's Hospital, Boston, MA. 2. Division of Pediatric Neurology, Boston Medical Center, Boston, MA. 3. Department of Pediatrics, Wake Forest University, Winston-Salem, NC. 4. Neuroepidemiology Unit, Department of Neurology, Boston Children's Hospital, Boston, MA. 5. Section of Neonatal-Perinatal Medicine, Department of Pediatrics, Yale University School of Medicine, New Haven, CT. 6. Department of Pediatrics, Division of Neonatology, Eastern Carolina University School of Medicine, Greenville, NC.
Abstract
OBJECTIVE: To examine the extent to which weight gain and weight status in the first 2 years of life relate to the risk of neurodevelopmental impairment in extremely preterm infants. STUDY DESIGN: In a cohort of 1070 infants born between 23 and 27 weeks' gestation, we examined weight gain from 7-28 days of life (in quartiles) and weight z-score at 12 and 24 months corrected age (in 4 categories: <-2; ≥-2, <-1; ≥1, <1; and ≥1) in relation to these adverse neurodevelopmental outcomes: Bayley-II mental development index <55, Bayley-II psychomotor development index <55, cerebral palsy, Gross Motor Function Classification System ≥1 (cannot walk without assistance), microcephaly. We adjusted for confounders in logistic regression, stratified by sex, and performed separate analyses including the entire sample, and excluding children unable to walk without assistance (motor impairment). RESULTS: Weight gain in the lowest quartile from 7-28 days was not associated with higher risk of adverse outcomes. Children with a 12-month weight z-score <-2 were at increased risk for all adverse outcomes in girls, and for microcephaly and Gross Motor Function Classification System ≥1 in boys. However, excluding children with motor impairment attenuated all associations except that of weight z-score <-2 with microcephaly in girls. Similarly, most associations of low weight z-score at 24 months with adverse outcomes were attenuated with exclusion of children with motor impairment. CONCLUSION: Excluding children who have gross motor impairment appears to eliminate the association of low weight status with neurodevelopmental impairments at 2 years in extremely preterm infants.
OBJECTIVE: To examine the extent to which weight gain and weight status in the first 2 years of life relate to the risk of neurodevelopmental impairment in extremely preterm infants. STUDY DESIGN: In a cohort of 1070 infants born between 23 and 27 weeks' gestation, we examined weight gain from 7-28 days of life (in quartiles) and weight z-score at 12 and 24 months corrected age (in 4 categories: <-2; ≥-2, <-1; ≥1, <1; and ≥1) in relation to these adverse neurodevelopmental outcomes: Bayley-II mental development index <55, Bayley-II psychomotor development index <55, cerebral palsy, Gross Motor Function Classification System ≥1 (cannot walk without assistance), microcephaly. We adjusted for confounders in logistic regression, stratified by sex, and performed separate analyses including the entire sample, and excluding children unable to walk without assistance (motor impairment). RESULTS:Weight gain in the lowest quartile from 7-28 days was not associated with higher risk of adverse outcomes. Children with a 12-month weight z-score <-2 were at increased risk for all adverse outcomes in girls, and for microcephaly and Gross Motor Function Classification System ≥1 in boys. However, excluding children with motor impairment attenuated all associations except that of weight z-score <-2 with microcephaly in girls. Similarly, most associations of low weight z-score at 24 months with adverse outcomes were attenuated with exclusion of children with motor impairment. CONCLUSION: Excluding children who have gross motor impairment appears to eliminate the association of low weight status with neurodevelopmental impairments at 2 years in extremely preterm infants.
Authors: Andrea Nash; Michael Dunn; Elizabeth Asztalos; Mary Corey; Bridget Mulvihill-Jory; Deborah L O'Connor Journal: Appl Physiol Nutr Metab Date: 2011-08-19 Impact factor: 2.665
Authors: Patrick H Casey; Leanne Whiteside-Mansell; Kathleen Barrett; Robert H Bradley; Regina Gargus Journal: Pediatrics Date: 2006-09 Impact factor: 7.124
Authors: A Lucas; M S Fewtrell; R Morley; A Singhal; R A Abbott; E Isaacs; T Stephenson; U M MacFadyen; H Clements Journal: Pediatrics Date: 2001-09 Impact factor: 7.124
Authors: T Michael O'Shea; Karl C K Kuban; Elizabeth N Allred; Nigel Paneth; Marcello Pagano; Olaf Dammann; Lisa Bostic; Kara Brooklier; Samantha Butler; Donald J Goldstein; Gail Hounshell; Cecelia Keller; Susan McQuiston; Alice Miller; Steve Pasternak; Susan Plesha-Troyke; Joan Price; Elaine Romano; Katherine M Solomon; Amanda Jacobson; Sjirk Westra; Alan Leviton Journal: Pediatrics Date: 2008-09 Impact factor: 7.124
Authors: Camilia R Martin; Yolanda F Brown; Richard A Ehrenkranz; T Michael O'Shea; Elizabeth N Allred; Mandy B Belfort; Marie C McCormick; Alan Leviton Journal: Pediatrics Date: 2009-07-27 Impact factor: 7.124
Authors: Jane J Lee; Kush Kapur; Ema G Rodrigues; Md Omar Sharif Ibne Hasan; Quazi Quamruzzaman; Robert O Wright; David C Bellinger; David C Christiani; Maitreyi Mazumdar Journal: Sci Total Environ Date: 2017-07-27 Impact factor: 7.963
Authors: Jordan D Reis; Kristine Tolentino-Plata; Roy Heyne; L Steven Brown; Charles R Rosenfeld; Maria Caraig; Patti J Burchfield; Luc P Brion Journal: J Perinatol Date: 2021-03-26 Impact factor: 3.225